High-dose chemotherapy of metastatic breast cancer: the end of the beginning?

by Crown, J.
Published 1997

Overcoming resistance and restoring sensitivity to HER2-targeted therapies in breast cancer

by Mohd Sharial, M. S. N., Crown, J., Hennessy, B. T.
Published 2012

Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma

by MAHGOUB, T., EUSTACE, A.J., COLLINS, D.M., WALSH, N., O'DONOVAN, N., CROWN, J.
Published 2015

Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells

by Caiazza, F, McGowan, P M, Mullooly, M, Murray, A, Synnott, N, O'Donovan, N, Flanagan, L, Tape, C J, Murphy, G, Crown, J, Duffy, M J
Published 2015

Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epiderman growth factor receptor 2-normal,...

by Eiermann, W., Pienkowski, T., Crown, J., Sadeghi, S., Chan, Arlene, Saleh, M., Sehdev, S., Provencher, L., Semiglazov, V., Press, M., Sauter, G., Lindsay, M., Riva, A., Buyse, M., Drevot, P., Taupin, H., Mackey, J.
Published 2011

Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, her2-positive early breast cancer...

by Au, H., Eiermann, W., Robert, N., Pienkowski, T., Crown, J., Martin, M., Pawlicki, M., Chan, Arlene, Mackey, J., Glaspy, J., Pintér, T., Liu, M., Fornander, T., Sehdev, S., Ferrero, J., Bée, V., Santana, M., Miller, D., Lalla, D., Slamon, D.
Published 2013

Adjuvant trastuzumab in HER2-positive breast cancer.

by Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., Mackey, J., Glaspy, J., Chan, Arlene, Pawlicki, M., Pinter, T., Valero, V., Liu, M., Sauter, G., von Minckwitz, G., Visco, F., Bee, V., Buyse, M., Bendahmane, B., Tabah-Fisch, I., Lindsay, M., Riva, A., Crown, J., Breast, C.
Published 2011